Morphic Holding Inc (MORF)
33.46
+2.00
(+6.36%)
USD |
NASDAQ |
Jun 25, 16:00
33.46
0.00 (0.00%)
After-Hours: 20:00
Morphic Cash from Operations (Quarterly): -46.39M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -46.39M |
| December 31, 2023 | -28.57M |
| September 30, 2023 | -29.25M |
| June 30, 2023 | -23.03M |
| March 31, 2023 | -31.45M |
| December 31, 2022 | -25.12M |
| September 30, 2022 | -24.89M |
| June 30, 2022 | -22.82M |
| March 31, 2022 | -28.15M |
| December 31, 2021 | -20.58M |
| September 30, 2021 | -24.58M |
| June 30, 2021 | -17.91M |
| March 31, 2021 | -20.39M |
| Date | Value |
|---|---|
| December 31, 2020 | -14.42M |
| September 30, 2020 | 3.731M |
| June 30, 2020 | -16.36M |
| March 31, 2020 | -18.94M |
| December 31, 2019 | -14.08M |
| September 30, 2019 | -13.70M |
| June 30, 2019 | -14.07M |
| March 31, 2019 | 0.188M |
| December 31, 2018 | 92.56M |
| September 30, 2018 | -5.319M |
| June 30, 2018 | -5.477M |
| March 31, 2018 | -5.426M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-46.39M
Minimum
Mar 2024
3.731M
Maximum
Sep 2020
-21.55M
Average
-21.70M
Median
Cash from Operations (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | -81.52M |
| Cytokinetics Inc | -129.51M |
| Amicus Therapeutics Inc | -29.70M |
| Insmed Inc | -184.04M |
| Madrigal Pharmaceuticals Inc | -149.16M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 31.37M |
| Cash from Financing (Quarterly) | 0.911M |
| Free Cash Flow | -128.61M |
| Free Cash Flow Per Share (Quarterly) | -0.9411 |
| Free Cash Flow Yield | -8.27% |